Verseon Corporation Additional Listing & Total Voting Rights (2760E)
July 03 2019 - 2:00AM
UK Regulatory
TIDMVERS
RNS Number : 2760E
Verseon Corporation
03 July 2019
July 3, 2019
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 8,476 new
shares of common stock ("Common Shares") of par value $0.001 each
to be admitted to trading on AIM pursuant to regularly scheduled
vesting of restricted stock units (the "Issuance").
The 8,476 Common Shares were issued to Dr. Hecht, a
non-executive Directors of the Company, in relation to the payment
of his Director's fees. Following the Issuance, Dr. Hecht will hold
115,370 Common Shares, representing 0.07% of the Company's issued
share capital.
The 8,476 new Common Shares issued pursuant to the Issuance will
rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on July 8,
2019 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 159,737,905 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 159,694,988. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
-Ends-
For further information, please contact
Verseon Corporation www.verseon.com
+1 (510) 225
Sebastian Wykeham / Tina Schlafly 9000
Arden Partners (NOMAD and Joint Broker)
Ruari McGirr / Ciaran Walsh/ Dan Gee-Summons
(Corporate Finance) / Fraser Marshall +44 (0) 20 7614
(Equity Sales) 5900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737
Simon Vane Percy 821 890
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr. Thomas Hecht
------------------------------ ------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------ ------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ ------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Verseon Corporation
------------------------------ ------------------------------------
b) LEI 213800CB2DUHDL6EPW12
------------------------------ ------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Restricted stock grant of Common
financial instrument, Shares of par value $0.001
type of instrument ISIN: USU9221J1171
Identification code
------------------------------ ------------------------------------
b) Nature of the transaction Vesting of restricted stock units
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 8,476
----------
------------------------------ ------------------------------------
Aggregated information
- Aggregated volume 8,476
d) - Price -
------------------------------ ------------------------------------
e) Date of the transaction 30 June 2019
------------------------------ ------------------------------------
f) Place of the transaction N/a
------------------------------ ------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEAPXAEAENEFF
(END) Dow Jones Newswires
July 03, 2019 02:00 ET (06:00 GMT)
Verseon (LSE:VERS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Verseon (LSE:VERS)
Historical Stock Chart
From Apr 2023 to Apr 2024